February 28, 2018 / 7:45 AM / in 10 months

BRIEF-Moberg Pharma Divests Balmex For $4.25 Million

Feb 28 (Reuters) - MOBERG PHARMA AB (PUBL):

* MOBERG PHARMA DIVESTS BALMEX® FOR $4.25 MILLION

* ENTERED INTO AGREEMENT WITH RANDOB LABS TO DIVEST BRAND BALMEX® FOR A TOTAL CONSIDERATION OF $4.25 MILLION (34.6 MILLION SEK) PLUS INVENTORY VALUE AT CLOSING​

* ‍DIVESTMENT IS EXPECTED TO RESULT IN A CAPITAL GAIN OF CIRCA $0.5 MILLION (4.4 MILLION SEK)​

* ‍TRANSACTION IS EXPECTED TO CLOSE IN APRIL​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below